ARZNEIMITTELABGABEVORRICHTUNG

Patent europeic · EP4037735 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4037735
Numer da la dumonda
EP20792812
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
29-09-2020
Publitgà
10-08-2022
Concedì
03-09-2025
La protecziun finescha il pli tard
28-09-2040
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
A61M 5/28 (2006.01)
A61M 5/315 (2006.01)
A61M 5/20 (2006.01)
A61M 5/32 (2006.01)
Prioritad
US 201962908504 P 30.09.2019
US 202062961048 P 14.01.2020
Dumonda PCT
PCT/US2020/053176 29.09.2020
Publicaziun PCT
WO2021/067206 08.04.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 17-06-2026

    Midada

    Published in Swissreg on 17.06.2026

  3. 11-06-2026

    Midada

    Published in Swissreg on 11.06.2026

  4. 01-10-2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  5. 03-09-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.09.2025

Partidas

Possessur

Amgen Inc.

One Amgen Center Drive, Thousand Oaks CA 91320, US

Inventur

FINKELSTEIN, Emil

Thousand Oaks, CA 91320-1799, US

EILERTSEN, Lars

Thousand Oaks, CA 91320-1799, US

SORENSEN, Michael

Thousand Oaks, CA 91320-1799, US

MADURO NORBO, Tobias

Thousand Oaks, CA 91320-1799, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.